Contact this trialFirst, we need to learn more about you.
Cancer Imaging Agent
Copper Cu 64 PSMA I&T for Prostate Adenocarcinoma
Recruiting2 awardsPhase 3
Los Angeles, California
This trial is testing a new imaging technique using a radioactive substance called copper Cu 64 PSMA I&T injection to detect recurrent prostate cancer in patients who have previously undergone surgery or radiation therapy for prostate cancer
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.